The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 4/Signature 1

From BugSigDB
Reviewed Marked as Reviewed by Folakunmi on 2024-4-9

Curated date: 2024/03/30

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 3D, Supp. Table S9

Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 immunotherapy in gastric cancer patients

Abundance in Group 1: increased abundance in Responders (gastric cancer)

NCBI Quality ControlLinks
Prevotella_9Prevotella_9
Bifidobacterium
Prevotella_2Prevotella_2
Lachnospira
Bacteroides
Ruminococcaceae bacterium UCG-005
Agathobacter

Revision editor(s): Scholastica